Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

BIK1 gene helps plants resist some pathogens but makes them more vulnerable to others.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Shikimic acid can promote hair growth and may help treat hair loss.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Using A132 hair dye with sunlight can cause skin damage and hair loss.

Norgalanthamine helps hair cells grow by activating certain pathways related to hair growth.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Shikimic acid promotes hair growth.

Upadacitinib effectively treated severe hair loss in a child.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Acetyl tetrapeptide-3 was successfully made for use in hair loss treatments.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The new wound dressing improves healing and tissue repair better than conventional dressings.